Cargando…
Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia
Respiratory syncytial virus (RSV) is a leading cause of serious seasonal lower respiratory tract infections (LRTI) in high-risk infants and children, with epidemics occurring annually in Saudi Arabia from October to March. Premature infants born at less than 29 weeks gestation with chronic lung dise...
Autores principales: | Al Aql, Fahad, Al-Hajjar, Sami, Bin Mahmoud, Latifa, Al-Alaiyan, Saleh, Tufenkji, Haysam, Bin-Hussain, Ibrahim, Abuzaid, Sameh, Peter, Vetha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372436/ https://www.ncbi.nlm.nih.gov/pubmed/30805466 http://dx.doi.org/10.1016/j.ijpam.2015.11.005 |
Ejemplares similares
-
Universal Screening for CCHD in Saudi Arabia: The Road to a ‘State of the Art’ Program
por: AlAql, Fahad, et al.
Publicado: (2020) -
Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children
por: al-Alaiyan, Saleh, et al.
Publicado: (2015) -
The need for hospital-based neonatal palliative care programs in Saudi Arabia
por: Al-Alaiyan, Saleh, et al.
Publicado: (2009) -
Aborting a Malformed Fetus: A Debatable Issue in Saudi Arabia: Retraction
por: Al-Alaiyan, Saleh
Publicado: (2014) -
Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
por: Taylor, Richard S.
Publicado: (2021)